Novartis Flu Vaccine Nightmare Ends; Worries Over Pharmacovigilance Overreaction Remain

As Italy, France, Switzerland and Austria lift bans on two Novartis flu vaccines, Germany’s more sober approach to specific batch suspensions proves more palatable for manufacturers.